At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 30 enrolled
Drug / intervention
Topical lyophilized exosomes applicationbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects on Facial Skin Aging After Topical Application of Exosomes With a Microneedling Device
Instituto de Oftalmología Fundación Conde de Valenciana·interventional·Posted Jan 28, 2026·Updated Jan 28, 2026
In Brief
A Phase 4 clinical trial evaluating Topical lyophilized exosomes application for Skin Aging. Completed, enrolled 30 participants across 1 site.
Detailed Summary
In this study, we evaluated the extent of reversal of facial dermal aging signs using topical lyophilized exosomes with a microneedling device
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Aging
CountriesMexico
Collaborators--
Timeline
Phase 4CompletedFinished
20252026
Enrollment StartJul 2024
Primary CompletionDec 2024
Study CompletionMar 2025
First PostedJan 2026
TodayJul 2026
First PostedJan 28, 2026
Enrollment StartJul 1, 2024
Primary CompletionDec 1, 2024
Study CompletionMar 1, 2025
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 5 months ago
Interventions
Topical lyophilized exosomes applicationbiological
The exosomes were applied to the facial area by dripping onto the skin and using a microneedling device to enhance dermal penetration. Three sessions, each four weeks apart, were performed for each subject